Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Internationally renowned restaurant, MR CHOW, is now open at Caesars Palace. The Las Vegas location is the seventh of the luxurious Beijing cuisine eatery, joining the ranks of notable hot spots in Miami, Malibu, New York City, Beverly Hills and the original location in London. From the moment guests arrive, MR CHOW will entertain and inspire, from the unparalleled design to the impeccable service to the notable cuisine.
“This union between Caesars Palace and MR CHOW is a dream come true,” said founder Michael Chow.
“We look forward to our guests experiencing MR CHOW as the culinary empire and reputation of Caesars Palace continues to grow,” said Gary Selesner, Caesars Palace regional president. “MR CHOW’s elevated Chinese cuisine and chic atmosphere perfectly complements the impressive culinary collection of celebrity-chef helmed restaurants of Bobby Flay, Gordon Ramsay, Nobu Matsuhisa, Guy Savoy and more. As we enter our 50th golden anniversary year at Caesars Palace, we continue to strive to delight our guests at the dining table, while contributing to the world renowned dining scene in Las Vegas.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7719251-caesars-palace-mr-chow/
Martin Amado is a TV personality, interior decorator, lifestyle expert, and contributing writer on the subject of home décor. For over ten years, he’s been the host/designer on the home makeover segment, Room for Improvement, seen on WSVN 7 News, a FOX affiliate station in Miami, FL. In addition to his work in the general market as a host/designer for HGTV (Home & Garden Network) on shows such as Small Space, Big Style and Decorating Cents, Martin has been featured on numerous Spanish-language media platforms airing nationally in the United States and throughout Latin America. He is currently a home décor contributor to Un Nuevo Día, Telemundo’s national morning program. Prior to that, he was the lead designer on Decorando Contigo airing for five seasons on Galavisión. His decorating segments have been featured on FOXLife on programs such as Tu Vida Más Simple and Hogar Express. He was chosen by Moen, the #1 faucet brand in the United States, to be their Home Décor & DIY Expert for three consecutive years on their SaturDIY: Moen Makeover webisode series for the general market. Most recently, he can be seen co-hosting on ION Television and on HuffPost Voces.Com as their DIY expert on the Baño Chic and Hogar Chic webisode series. Martin has shared his decorating and lifestyle tips in the pages of Vista Magazine, People En Español, Latina Magazine, TV y Novelas, HuffPost Voces and Qué Rica Vida. His experience also includes being an On-Air Guest Expert for the HGTV Home brand on the Home Shopping Network. He draws on his keen eye for design, experience as a visual merchandiser, and savvy shopping skills to help homeowners realize that a beautifully-decorated space can be within their reach. Martin works exclusively with clients through his home styling company, The WOW Factor!, Inc., where he specializes in one-day makeovers and working with a minimal budget to achieve the decorator look for less! Please visit www.martinamado.com for additional information and press including features inside People En Español and other publications. You may follow him on Twitter @martinamadotv, join his Facebook fan page: Martin Amado: Home Décor & Lifestyle Expert, subscribe to his YouTube channel: Martin Amado and follow him on Instagram: @martinamadotv for more decorating tips and ideas.
